Synopsis: Nabiha Saklayen, PhD, is the Co-Founder and CEO of Cellino Biotech, a company working to democratize access to personalized stem cell-based therapies for patients at scale. Nabiha joins host Rahul Chaturvedi for a discussion about her entrepreneurial journey and her learning process in the early days of building a start-up. She talks about opportunities and challenges in the field of regenerative medicine and the exciting science her team is pursuing at Cellino to use stem cell-derived regenerative medicines to treat diseases such as Parkinson’s, diabetes, and heart disease. She also touches on changes and trends in biotech she’s observed over the years. Nabiha first appeared on the Biotech2050 podcast for its 100th episode - listen here: https://on.soundcloud.com/HkAxq Biography: Nabiha Saklayen is the Co-Founder and CEO of Cellino. Cellino’s proprietary technology makes personalized stem cell-derived therapies scalable for the first time. Nabiha was selected as a Pioneer in MIT Tech Review's 35 Innovators under 35 list for her patented inventions in cellular laser editing. She received her Ph.D. in Physics from Harvard University as a Howard Hughes Medical Institute (HHMI) International Fellow. She is also the inaugural Tory Burch Foundation Fellow in Genomics at the Innovative Genomics Institute led by Nobel Laureate Dr. Jennifer Doudna. Nabiha is also a TED speaker and co-creator of I Am A Scientist, an educational program running in 50 states that inspires children to explore science.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related